1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. TREVI THERAPEUTICS INC
Trevi Therapeutics Inc XNAS: TRVI

Trevi Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

about

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary f...

Read More
7.55 -0.09 (-1.18%)
New 52W High in past week
1.3M
XNAS Volume

XNAS 29 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Trevi Therapeutics Inc is on 08 Aug 2025 for the purpose of Trevi Therapeutics Inc Second Quarter Earnings Results for 2025 See details
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
2.7 / 100
Momentum Score
Technically Bullish
75.6 / 100
Analyst Price Target
No estimates available

19

S

8

W

3

O

1

T

SWOT Analysis

Trevi Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..